Grigoriadis D - Search Results

1

Dopamine D2 receptor binding sites for agonists. A tetrahedral model.

Seeman P, Watanabe M, Grigoriadis D, Tedesco JL, George SR, Svensson U, Nilsson JL, Neumeyer JL. Seeman P, et al. Among authors: grigoriadis d. Mol Pharmacol. 1985 Nov;28(5):391-9. Mol Pharmacol. 1985. PMID: 2932631

2

Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone.

Niznik HB, Grigoriadis DE, Seeman P. Niznik HB, et al. Among authors: grigoriadis de. FEBS Lett. 1986 Dec 1;209(1):71-6. doi: 10.1016/0014-5793(86)81086-9. FEBS Lett. 1986. PMID: 2948835 Free article.

3

2-Haloaporphines as potent dopamine agonists.

Ramsby S, Neumeyer JL, Grigoriadis D, Seeman P. Ramsby S, et al. Among authors: grigoriadis d. J Med Chem. 1989 Jun;32(6):1198-201. doi: 10.1021/jm00126a009. J Med Chem. 1989. PMID: 2524592

4

[3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.

Grigoriadis D, Seeman P. Grigoriadis D, et al. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan;332(1):21-5. doi: 10.1007/BF00633192. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 2869417

5

Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonist.

Horn AS, Tepper P, Van der Weide J, Watanabe M, Grigoriadis D, Seeman P. Horn AS, et al. Among authors: grigoriadis d. Pharm Weekbl Sci. 1985 Oct 25;7(5):208-11. doi: 10.1007/BF02307578. Pharm Weekbl Sci. 1985. PMID: 2933633

6

Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide.

Grigoriadis D, Seeman P. Grigoriadis D, et al. J Neurochem. 1985 Jun;44(6):1925-35. doi: 10.1111/j.1471-4159.1985.tb07189.x. J Neurochem. 1985. PMID: 3157782

7

Dopamine D2 receptor dissociation constant for spiperone: identical values using 3H-labeled agonist or 3H-labeled antagonist.

Seeman P, Grigoriadis D. Seeman P, et al. Among authors: grigoriadis d. Biochem Pharmacol. 1985 Nov 15;34(22):4065-6. doi: 10.1016/0006-2952(85)90388-0. Biochem Pharmacol. 1985. PMID: 4062976 No abstract available.

8

The dopamine/neuroleptic receptor.

Grigoriadis D, Seeman P. Grigoriadis D, et al. Can J Neurol Sci. 1984 Feb;11(1 Suppl):108-13. doi: 10.1017/s0317167100046242. Can J Neurol Sci. 1984. PMID: 6231978

9

Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.

Niznik HB, Grigoriadis DE, Pri-Bar I, Buchman O, Seeman P. Niznik HB, et al. Among authors: grigoriadis de. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jun;329(4):333-43. doi: 10.1007/BF00496365. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 2863760

10

Glycoprotein nature of D2 dopamine receptors.

Grigoriadis DE, Niznik HB, Jarvie KR, Seeman P. Grigoriadis DE, et al. FEBS Lett. 1988 Jan 25;227(2):220-4. doi: 10.1016/0014-5793(88)80902-5. FEBS Lett. 1988. PMID: 2962888 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters